Achieve Life Sciences, Inc. (ACHV)
NASDAQ
Market Cap
$105.92M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
315 of 951
Rank in Industry
191 of 544
Largest Insider Buys in Sector
ACHV Stock Price History Chart
ACHV Stock Performance
About Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Insider Activity of Achieve Life Sciences, Inc.
Over the last 12 months, insiders at Achieve Life Sciences, Inc. have bought $91,700 and sold $0 worth of Achieve Life Sciences, Inc. stock.
On average, over the past 5 years, insiders at Achieve Life Sciences, Inc. have bought $40,300 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Bencich John (CEO) — $45,850. Stewart Richard Alistair (Executive Chairman) — $45,850.
The last purchase of 10,000 shares for transaction amount of $45,850 was made by Bencich John (CEO) on 2024‑03‑04.
List of Insider Buy and Sell Transactions, Achieve Life Sciences, Inc.
| 2024-03-04 | CEO | 10,000 0.0492% | $4.58 | $45,850 | +2.70% | |||
| 2024-03-04 | Executive Chairman | 10,000 0.0492% | $4.58 | $45,850 | +2.70% | |||
| 2023-05-30 | CEO | 5,000 0.0246% | $5.50 | $27,500 | -26.44% | |||
| 2022-11-18 | CEO | 22,000 – | $0 | $0 | +107.53% | |||
| 2021-05-27 | CEO | 6,000 0.0716% | $7.00 | $42,000 | -3.40% | |||
| 2019-06-11 | Sale | 10 percent owner | 312,145 4.6633% | $3.11 | $972,288 | -71.03% | ||
| 2019-06-11 | 10 percent owner | 12,813 0.2335% | $3.80 | $48,689 | -71.03% | |||
| 2019-05-23 | Chairman & CEO | 17,500 0.2417% | $3.61 | $63,093 | -74.93% | |||
| 2016-08-19 | Sale | CFO | 2,760 0.0092% | $0.57 | $1,573 | -21.05% | ||
| 2016-06-13 | Sale | President and CEO | 9,712 0.032% | $1.03 | $9,959 | -50.96% | ||
| 2016-06-13 | Sale | EVP, CMO | 2,874 0.0095% | $1.03 | $2,947 | -50.96% | ||
| 2016-03-15 | Sale | President and CEO | 24,066 0.0807% | $0.83 | $19,975 | -30.12% | ||
| 2016-03-15 | Sale | EVP, CMO | 6,508 0.0218% | $0.83 | $5,402 | -30.12% | ||
| 2016-03-15 | Sale | CFO | 1,668 0.0056% | $0.83 | $1,384 | -30.12% | ||
| 2015-08-18 | Sale | CFO | 2,854 0.0103% | $2.76 | $7,877 | -62.45% | ||
| 2015-06-12 | Sale | President and CEO | 9,142 0.0381% | $2.69 | $24,592 | -56.36% | ||
| 2015-06-12 | Sale | EVP, CMO | 2,816 0.0117% | $2.69 | $7,575 | -56.36% | ||
| 2015-05-20 | Sale | President and CEO | 15,086 0.0639% | $1.88 | $28,362 | +11.11% | ||
| 2015-05-20 | Sale | EVP, CMO | 4,184 0.0177% | $1.88 | $7,866 | +11.11% | ||
| 2014-08-13 | Sale | President and CEO | 36,682 0.1682% | $3.17 | $116,282 | -30.49% |
Insider Historical Profitability
<0.0001%
| Bencich John | CEO | 76724 0.2231% | $3.08 | 4 | 3 | <0.0001% |
| Stewart Richard Alistair | Executive Chairman | 38501 0.112% | $3.08 | 2 | 0 | <0.0001% |
| COHEN STEVEN A/SAC CAPITAL MGMT LP | 10 percent owner | 1454752 4.2302% | $3.08 | 1 | 0 | |
| S A C CAPITAL MANAGEMENT L L C | 10 percent owner | 1454752 4.2302% | $3.08 | 1 | 0 | |
| SAC CAPITAL ADVISORS LLC | 10 percent owner | 1454752 4.2302% | $3.08 | 1 | 0 | |
| ARMISTICE CAPITAL, LLC | 10 percent owner | 1026000 2.9834% | $3.08 | 1 | 1 | <0.0001% |
| SAC CAPITAL ASSOCIATES LLC | 10 percent owner | 902376 2.624% | $3.08 | 1 | 0 | |
| H.I.G. ONCOGENEX, INC. | 10 percent owner | 545512 1.5863% | $3.08 | 0 | 2 | |
| Cormack Scott Daniel | President and CEO | 129428 0.3764% | $3.08 | 1 | 12 | |
| JACOBS CINDY | EVP, CMO | 77416 0.2251% | $3.08 | 0 | 8 | |
| VENTURES WEST CAPITAL LTD | 10 percent owner | 41763 0.1214% | $3.08 | 0 | 1 | |
| Anderson Stephen Charles | CFO and Secretary | 13000 0.0378% | $3.08 | 3 | 0 | |
| MARTINO MICHAEL A | 11000 0.032% | $3.08 | 0 | 10 | ||
| DUNBAR GEORGE W JR | director | 3250 0.0095% | $3.08 | 1 | 0 | |
| Lawrence Cameron William | Principal Financial Officer | 3050 0.0089% | $3.08 | 1 | 0 | |
| PARKER H STEWART | director | 3000 0.0087% | $3.08 | 1 | 0 | |
| IVY ROBERT E | director | 1700 0.0049% | $3.08 | 0 | 5 | |
| Wyrick Susan D. | PAO | 1312 0.0038% | $3.08 | 0 | 3 | |
| GOLDSTEIN JACK | director | 1000 0.0029% | $3.08 | 1 | 0 | |
| MATTINGLY MARTIN A | director | 1000 0.0029% | $3.08 | 1 | 0 | |
| WINSTEAD DWIGHT | director | 0 0% | $3.08 | 0 | 2 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Franklin Templeton Investments | $17.19M | 17.37 | 5.96M | New | +$17.19M | 0.01 | |
| Sofinnova | $6.9M | 4.42 | 1.52M | New | +$6.9M | 0.01 | |
| The Vanguard Group | $4.31M | 2.76 | 948,441 | +56.58% | +$1.56M | <0.0001 | |
| Altium Capital Management Lp | $3.8M | 2.43 | 835,470 | New | +$3.8M | 0.45 | |
| Nantahala Capital Management Llc | $2.97M | 1.9 | 654,000 | New | +$2.97M | 0.14 | |
| Cvi Holdings Llc | $2.58M | 1.65 | 567,192 | New | +$2.58M | 2.69 | |
| Alyeska Investment Group L P | $2.14M | 1.37 | 471,000 | New | +$2.14M | 0.01 | |
| Shay Capital Llc | $2.05M | 1.31 | 450,000 | -37.93% | -$1.25M | 0.32 | |
| Long Focus Capital Management Llc | $1.13M | 0.72 | 248,099 | 0% | +$0 | 0.13 | |
| Simplify Asset Management Inc | $990,106.00 | 0.63 | 217,845 | New | +$990,106.00 | 0.1 | |
| Geode Capital Management | $940,079.00 | 0.6 | 206,784 | +11.82% | +$99,375.13 | <0.0001 | |
| Millennium Management LLC | $880,085.00 | 0.56 | 193,638 | New | +$880,085.00 | <0.01 | |
| LINSCO PRIVATE LEDGER CORP | $829,462.00 | 0.53 | 182,500 | +2.24% | +$18,179.99 | <0.0001 | |
| Raymond James Associates | $690,154.00 | 0.44 | 151,849 | -1.93% | -$13,544.11 | <0.0001 | |
| Northern Trust | $448,737.00 | 0.29 | 98,732 | -3.19% | -$14,780.34 | <0.0001 | |
| Wells Fargo | $312,719.00 | 0.2 | 68,805 | -1.55% | -$4,935.87 | <0.0001 | |
| State Street | $250,957.00 | 0.16 | 55,216 | -12.79% | -$36,814.54 | <0.0001 | |
| BlackRock | $238,299.00 | 0.15 | 52,431 | 0% | +$0 | <0.0001 | |
| Susquehanna International Group | $202,948.00 | 0.13 | 44,653 | New | +$202,948.00 | <0.0001 | |
| Balyasny Asset Management Llc | $126,110.00 | 0.08 | 27,747 | New | +$126,110.00 | <0.0001 | |
| J. Goldman & Company | $111,571.00 | 0.07 | 24,548 | -63.63% | -$195,221.98 | <0.01 | |
| Goldman Sachs | $100,981.00 | 0.07 | 22,218 | New | +$100,981.00 | <0.0001 | |
| Bank of America | $101,604.00 | 0.07 | 22,355 | +242.24% | +$71,915.91 | <0.0001 | |
| Manchester Financial Inc | $86,810.00 | 0.06 | 19,100 | 0% | +$0 | 0.03 | |
| Virtu Financial Llc | $59,000.00 | 0.04 | 12,930 | New | +$59,000.00 | 0.01 | |
| OMERS | $54,540.00 | 0.04 | 12,000 | New | +$54,540.00 | <0.01 | |
| Jefferies Financial Group | $52,268.00 | 0.03 | 11,500 | New | +$52,268.00 | <0.01 | |
| Renaissance Technologies | $49,000.00 | 0.03 | 10,700 | -1.83% | -$915.89 | <0.0001 | |
| Advisor Group Holdings Inc | $44,787.00 | 0.03 | 9,852 | -83.54% | -$227,299.03 | <0.0001 | |
| Group One Trading | $29,792.00 | 0.02 | 6,555 | -48.45% | -$27,996.75 | <0.0001 | |
| Qube Research & Technologies | $18,312.00 | 0.01 | 4,029 | +402,800% | +$18,307.46 | <0.0001 | |
| Stephens Consulting Llc | $13,635.00 | 0.01 | 3,000 | 0% | +$0 | 0.01 | |
| Tower Research Capital | $14,280.00 | 0.01 | 3,142 | +15.86% | +$1,954.30 | <0.0001 | |
| Comerica | $11,362.00 | 0.01 | 2,500 | 0% | +$0 | <0.0001 | |
| Macquarie Group | $5,000.00 | <0.01 | 1,047 | New | +$5,000.00 | <0.0001 | |
| Northwestern Mutual Wealth Management Co | $23.00 | <0.01 | 5 | New | +$23.00 | <0.0001 | |
| UBS | $9.00 | <0.01 | 2 | 0% | +$0 | <0.0001 | |
| Cornerstone Planning Group Llc | $474.00 | <0.01 | 100 | New | +$474.00 | <0.0001 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.